Aspergillus Galactomannan Antigen in the Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients
暂无分享,去创建一个
Nina Singh | D. Paterson | J. Pilewski | S. Studer | K. McCurry | M. Durkin | J. Wheat | S. Husain | M. Crespo | B. Johnson | Lisa McLaughlin | C. Bentsen | N. Singh | Christopher Bentsen
[1] D. Pakstis,et al. Voriconazole Prophylaxis in Lung Transplant Recipients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] A. Francesconi,et al. Characterization and Comparison of Galactomannan Enzyme Immunoassay and Quantitative Real-Time PCR Assay for Detection of Aspergillus fumigatus in Bronchoalveolar Lavage Fluid from Experimental Invasive Pulmonary Aspergillosis , 2006, Journal of Clinical Microbiology.
[3] J. Fine,et al. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] A. Humar,et al. American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] R. Porcher,et al. Occurrence and Kinetics of False-Positive Aspergillus Galactomannan Test Results following Treatment with β-Lactam Antibiotics in Patients with Hematological Disorders , 2006, Journal of Clinical Microbiology.
[6] T. Starzl,et al. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. , 2005, The Journal of thoracic and cardiovascular surgery.
[7] Nina Singh,et al. Aspergillus Infections in Transplant Recipients , 2005, Clinical Microbiology Reviews.
[8] J. Latgé,et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis , 1996, European Journal of Clinical Microbiology and Infectious Diseases.
[9] W. Leisenring,et al. Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid , 2004, Journal of Clinical Microbiology.
[10] T. Walsh,et al. Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In Vitro, In Vivo, and Clinical Properties of the Drug-Antigen Interaction , 2004, Journal of Clinical Microbiology.
[11] J. Verhaegen,et al. Prospective clinical evaluation of lower cut‐offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients , 2004, British journal of haematology.
[12] S. Balajee,et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. , 2004, The Journal of infectious diseases.
[13] Nina Singh,et al. Reactivity of Platelia Aspergillus Galactomannan Antigen with Piperacillin-Tazobactam: Clinical Implications Based on Achievable Concentrations in Serum , 2004, Antimicrobial Agents and Chemotherapy.
[14] Jost B Jonas,et al. GEE approaches to marginal regression models for medical diagnostic tests , 2004, Statistics in medicine.
[15] Nina Singh,et al. Prospective Assessment of Platelia™Aspergillus Galactomannan Antigen for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] M. Cannesson,et al. Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia , 2004, Intensive Care Medicine.
[17] A. Sulahian,et al. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. , 2003, The New England journal of medicine.
[18] P. Martín-Dávila,et al. Voriconazole in the Treatment of Invasive Mold Infections in Transplant Recipients , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[19] H. Hoogsteden,et al. Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis , 2003, British journal of haematology.
[20] Nina Singh,et al. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[21] J. Verschakelen,et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. , 2002, The Journal of infectious diseases.
[22] J. Bergerat,et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] D. Denning,et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] R. Krahl,et al. Aspergillus detection in bronchoscopically acquired material. Significance and interpretation , 2001, Mycoses.
[25] F. Derouin,et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4‐year prospective study , 2001, Cancer.
[26] J. Curfs,et al. Failure To Detect Circulating Aspergillus Markers in a Patient with Chronic Granulomatous Disease and Invasive Aspergillosis , 2000, Journal of Clinical Microbiology.
[27] H. Verbrugh,et al. Quantitative Galactomannan Detection Is Superior to PCR in Diagnosing and Monitoring Invasive Pulmonary Aspergillosis in an Experimental Rat Model , 2000, Journal of Clinical Microbiology.
[28] O. Lehtonen,et al. Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome. , 2000, Scandinavian journal of infectious diseases.
[29] G. Verhoef,et al. Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis , 1999, Journal of Clinical Microbiology.
[30] M. Siemann,et al. False‐positive results in premature infants with the Platelia®Aspergillus sandwich enzyme‐linked immunosorbent assay , 1998, Mycoses.
[31] J. Meis,et al. Serial monitoring ofAspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples , 1997, Infection.
[32] J. Meis,et al. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan , 1997, Journal of clinical microbiology.
[33] J. Latgé,et al. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies , 1995, Journal of clinical microbiology.
[34] C. Keller,et al. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation. , 1995, Chest.
[35] R. Kappe,et al. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test , 1993, Journal of clinical microbiology.
[36] J. Bennett,et al. Receptor-mediated clearance of Aspergillus galactomannan. , 1987, The Journal of infectious diseases.
[37] K Y Liang,et al. Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.
[38] H. Kauffman,et al. Comparison of antibody measurements against Aspergillus fumigatus by means of double-diffusion and enzyme-linked immunosorbent assay (ELISA). , 1983, The Journal of allergy and clinical immunology.